A First-In-Human study of HS-10383, a Selective P2X3 Receptor Antagonist for the treatment of Refractory or Unexplained Chronic Cough, in Healthy Chinese Subjects

被引：0
|
作者：
Li, Qian [1 ,2 ]
Chen, Ke-Guang [1 ,2 ]
Zhang, Ye-Hui [1 ,2 ]
Zhou, Hai-Yan [1 ,2 ]
Ye, Pan-Pan [1 ,2 ]
Song, Lin-Lin [1 ,2 ]
Zhao, Fu-Rong [1 ,2 ]
Shi, Jin-Yi [1 ,2 ]
Wu, Qiong [3 ]
Yu, Xiang-Qing [3 ]
Pan, Chao [3 ]
Yuan, Dong [3 ]
Xu, Miao [3 ]
Xing, Aiping [3 ]
Yang, Xin-Mei [1 ,2 ]
Zhao, Wei [1 ,2 ,4 ]
机构：
[1] Shandong First Med Univ, Dept Clin Pharm, Affiliated Hosp 1, Jinan, Peoples R China
[2] Shandong Prov Qianfoshan Hosp, Shandong Engn & Technol Res Ctr Pediat Drug Dev, Shandong Med & Hlth Key Lab Clin Pharm, Jinan, Peoples R China
[3] Jiangsu Hansoh Pharmaceut Grp Co Ltd, Dept Clin Pharm, Lianyungang, Peoples R China
[4] Shandong Univ, Sch Pharmaceut Sci, Minist Educ,Dept Clin Pharm, Key Lab Chem Biol,Cheeloo Coll Med, Jinan, Peoples R China
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AO13-6
引用
收藏
页码：60 / 61
页数：2
相关论文
共 50 条
  • [21] Gefapixant, a P2X3 receptor antagonist, for the treatment of refractory or unexplained chronic cough: a randomised, double-blind, controlled, parallel-group, phase 2b trial
    Smith, Jaclyn A.
    Kitt, Michael M.
    Morice, Alyn H.
    Birring, Surinder S.
    McGarvey, Lorcan P.
    Sher, Mandel R.
    Li, Yu-Ping
    Wu, Wen-Chi
    Xu, Zhi Jin
    Muccino, David R.
    Ford, Anthony P.
    LANCET RESPIRATORY MEDICINE, 2020, 8 (08): : 775 - 785
  • [22] The effect of baseline factors on treatment response with MK-7264, a P2X3 antagonist, in refractory chronic cough.
    Smith, Jaclyn
    Mcgarvey, Lorcan P.
    Morice, Alyn H.
    Birring, Surinder S.
    Kitt, Michael M.
    Sher, Mandel R.
    Tershakovec, Andrew M.
    Wu, Wen-Chi
    Xu, Zhi Jin
    Muccino, David R.
    EUROPEAN RESPIRATORY JOURNAL, 2018, 52
  • [23] Burden of Cough in Refractory Chronic Cough Patients Enrolled in A Phase 2b Study of the P2X3 Antagonist BLU-5937
    Goldsobel, Alan
    Blaiss, Michael
    Sher, Mandel
    Birring, Surinder
    Smith, Jaclyn
    Harvey, Laurent
    Yang, Ronghua
    Bonuccelli, Catherine
    Garin, Margaret
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2023, 151 (02) : AB161 - AB161
  • [24] Design of SOOTHE, a Phase 2b Dose Finding Study with BLU-5937, a Selective P2X3 Antagonist, in Refractory Chronic Cough
    Bonuccelli, C. M.
    Smith, J.
    Birring, S. S.
    Blaiss, M.
    Dicpinigaitis, P.
    Sher, M. R.
    Garceau, D.
    Chauret, N.
    Garin, M.
    Harvey, L.
    Carroll, K. J.
    Shaw, J. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [25] Eliapixant (BAY 1817080), a P2X3 receptor antagonist, in refractory chronic cough: a randomised, placebo-controlled, crossover phase 2a study
    Morice, Alyn
    Smith, Jaclyn A.
    McGarvey, Lorcan
    Birring, Surinder S.
    Parker, Sean M.
    Turner, Alice
    Hummel, Thomas
    Gashaw, Isabella
    Fels, Lueder
    Klein, Stefan
    Francke, Klaus
    Friedrich, Christian
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58 (05)
  • [26] Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
    Alyn H. Morice
    Surinder S. Birring
    Jaclyn A. Smith
    Lorcan P. McGarvey
    Jonathan Schelfhout
    Allison Martin Nguyen
    Zhi Jin Xu
    Wen-Chi Wu
    David R. Muccino
    Mandel R. Sher
    Lung, 2021, 199 : 121 - 129
  • [27] Characterization of Patients With Refractory or Unexplained Chronic Cough Participating in a Phase 2 Clinical Trial of the P2X3-Receptor Antagonist Gefapixant
    Morice, Alyn H.
    Birring, Surinder S.
    Smith, Jaclyn A.
    McGarvey, Lorcan P.
    Schelfhout, Jonathan
    Martin Nguyen, Allison
    Xu, Zhi Jin
    Wu, Wen-Chi
    Muccino, David R.
    Sher, Mandel R.
    LUNG, 2021, 199 (02) : 121 - 129
  • [28] A Phase 2 Dose-Escalation Study With Af-219, A P2x3 Antagonist For The Treatment Of Chronic Cough
    Smith, J. A.
    Kitt, M.
    Sher, M.
    Butera, P.
    Ford, A. P.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193
  • [29] Design of phase 2b randomised controlled trial of S-600918, P2X3 receptor antagonist for refractory chronic cough
    Ishihara, Hiroyuki
    Hida, Hideaki
    Machida, Mitsuaki
    Tsuda, Yoshiyuki
    Miyazaki, Sayaka
    EUROPEAN RESPIRATORY JOURNAL, 2020, 56
  • [30] P2X3 receptor antagonist (AF-219) in refractory chronic cough: a randomised, double-blind, placebo-controlled phase 2 study
    Abdulqawi, Rayid
    Dockry, Rachel
    Holt, Kimberley
    Layton, Gary
    McCarthy, Bruce G.
    Ford, Anthony P.
    Smith, Jaclyn A.
    LANCET, 2015, 385 (9974): : 1198 - 1205
12345